Come True Biomedical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2018; Announces Impairment Loss for the Third Quarter of 2018
For the nine months, sales was TWD 74.770 million compared to TWD 129.420 million a year ago. Net loss was TWD 49.511 million compared to TWD 51.030 million a year ago. Basic loss per share was TWD 1.56 compared to TWD 1.61 a year ago.
For the quarter, the company reported impairment loss of TWD 24.00 million.